J01DC02 • cefuroxime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins
Cefuroxime is a second-generation cephalosporin antibiotic used to treat moderate bacterial infections. It is indicated for upper respiratory tract infections (such as sinusitis, tonsillitis, or pharyngitis), lower respiratory tract infections (bronchitis, pneumonia), urinary tract infections, otitis media, skin and soft tissue infections, as well as some bone and joint infections.
Cefuroxime works by inhibiting bacterial cell wall synthesis, killing the bacteria responsible for the infection. It is available in tablet, oral suspension, or injectable solution form.
Side effects may include nausea, diarrhea, abdominal pain, skin rashes, or allergic reactions. In rare cases, it can cause pseudomembranous colitis or severe hypersensitivity reactions. It is contraindicated in patients with allergies to cephalosporins or penicillins.
Substance: cefuroxime
Date of last drug list: 01-12-2025
Commercial code: W71455001
Concentration: 1.5g
Pharmaceutical form: powder for injection
Quantity: 1
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: SWYSSI AG - GERMANIA
Holder: SWYSSI AG - GERMANIA
Number: 16279/2025/01
Shelf life: 3 years-dupa ambalare pentru comercialziare;after the first opening of the bottle-it is used immediately
powder for intramuscular / intravenous injection solution
powder for intravenous injection solution
powder for intravenous / infusion solution for injection
powder for injection / infusion solution
powder for intravenous / intramuscular injection solution / suspension
powder for suspension for intramuscular injection / solution for intramuscular / intraveno
powder for intramuscular injection suspension / intravenous injection solution
powder for injection suspension or intramuscular / intravenous injection solution